258 filings
8-K
MDXG
Mimedx Group Inc
7 Jun 24
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
8-K
MDXG
Mimedx Group Inc
27 Mar 24
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
8:24am
8-K
MDXG
Mimedx Group Inc
4 Mar 24
MIMEDX Announces Appointment of Two New Independent Directors
8:11am
8-K
MDXG
Mimedx Group Inc
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
8-K
tvlx5plp8sp2oyt8z
22 Jan 24
MIMEDX Announces Improved Capital Structure with New Senior
8:09am
8-K
1j57ozipp93itvu
28 Dec 23
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
4:30pm
8-K
kfhpzq8aboeaimih
13 Nov 23
MIMEDX to Participate in Upcoming Investor Conferences
8:14am
8-K
09yi7gpvw119u0w uf
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
uda104
5 Sep 23
Departure of Directors or Certain Officers
5:00pm
8-K
kjbfunfa
5 Sep 23
MIMEDX to Present at Upcoming Investor Conferences
8:38am
8-K
6cqzhk yrknmogl9
1 Aug 23
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
4:03pm
8-K
4td7 8rzhueh2
5 Jul 23
MIMEDX Appoints Doug Rice as Chief Financial Officer
9:02am
8-K
uqp45r
20 Jun 23
Departure of Directors or Certain Officers
4:03pm
8-K
bcwhi2q2k1r
14 Jun 23
Departure of Directors or Certain Officers
4:23pm
8-K
ci44jgr
2 May 23
MIMEDX Announces First Quarter 2023 Operating and Financial Results
4:06pm
8-K
fbip1m1u9nijgty3l3x
24 Mar 23
MIMEDX Announces Chief Financial Officer Transition
4:17pm
8-K
sjku4e8skyjinul
28 Feb 23
MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results
4:08pm
8-K
iyop 78rpsesnfh
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
5:27pm
8-K
z4ym273129qyh9a
30 Jan 23
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
8:14am